Skip to main content

Teladoc stock has tumbled. Goldman Sachs sees a major recovery.

By Barron's  
   February 13, 2022

Teladoc Health stock has shed half its value in the past six months. An analyst at Goldman Sachs says it's time to buy shares of the virtual-healthcare firm.

Full story


Get the latest on healthcare leadership in your inbox.